Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 23 of 23 entries
View as:

Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04747717 Org: User:
Start: 10/01/20 End: 10/01/25 Due: 10/01/26

Sentinel Lymph Node Biopsy in Stage AI-IIA Germ Cell Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06133699 Org: User:
Start: 11/08/23 End: 11/30/25 Due: 11/30/26

Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02506790 Org: User:
Start: 07/31/15 End: 08/31/22 Due: 08/31/23

Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB)

Phase: N/A Priority: Normal
NCT ID: NCT04293796 Org: User:
Start: 10/08/19 End: 12/10/28 Due: 12/10/29

Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Colon Cancer Resections Versus no Bowel Preparation

Phase: N/A Priority: Normal
NCT ID: NCT05546892 Org: User:
Start: 02/10/23 End: 09/30/25 Due: 09/30/26

Survival Monitoring in Russian Cancer Registries

Phase: N/A Priority: Normal
NCT ID: NCT06043947 Org: User:
Start: 08/01/23 End: 12/31/25 Due: 12/31/26

Autologous Dendritic Cell Vaccine in Patients With Soft Tissue Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT01883518 Org: User:
Start: 06/30/13 End: 09/30/20 Due: 09/30/21

Leflunomide or Combination of MEK Inhibitor and Hydroxychloroquine for Refractory Patients With RAS Mutations

Phase: N/A Priority: Normal
NCT ID: NCT06229340 Org: User:
Start: 10/03/23 End: 10/01/26 Due: 10/01/27

Biobank and Register of Patients With Agresive Tumors for Translational and Analytical Research

Phase: N/A Priority: Normal
NCT ID: NCT05539677 Org: User:
Start: 09/30/98 End: 12/31/30 Due: 12/31/31

ICG Fluorescence Guided Lymph Node Mapping for Determination of Bowel Resection Margins in Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05468827 Org: User:
Start: 07/26/22 End: 03/14/24 Due: 03/14/25

Combined Treatment of Patients With Soft Tissue Sarcoma Including Preoperative Stereotactic Radiation Therapy and Postoperative Conformal Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT04330456 Org: User:
Start: 02/01/20 End: 07/01/28 Due: 07/01/29

HDR Brachytherapy vs SABR in Early-intermediate Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04870567 Org: User:
Start: 04/01/18 End: 04/30/25 Due: 04/30/26

Neoadjuvant FDC With Melatonin or Metformin for Locally Advanced Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT02506777 Org: User:
Start: 07/31/15 End: 08/31/20 Due: 08/31/21

Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas

Phase: N/A Priority: Normal
NCT ID: NCT06669013 Org: User:
Start: 05/20/21 End: 09/30/25 Due: 09/30/26

Multicentral Preventive Antibiotics With Cystectomy Within Enhanced Recovery After Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05392634 Org: User:
Start: 02/02/22 End: 11/01/23 Due: 11/01/24

High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06418789 Org: User:
Start: 03/01/24 End: 03/01/29 Due: 03/01/30

Study of Oncological Outcomes of D3 Lymph Node Dissection in Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03009227 Org: User:
Start: 02/03/17 End: 01/31/25 Due: 01/31/26

Comparison of Melatonin or Metformin and Dacarbazine Combination Versus Dacarbazine Alone in Disseminated Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT02190838 Org: User:
Start: 04/30/14 End: 12/31/18 Due: 12/31/19

CT Screening For Lung Cancer in High Risk Patients: the Russian Study.

Phase: N/A Priority: Normal
NCT ID: NCT01752647 Org: User:
Start: 11/30/12 End: 09/30/16 Due: 09/30/17

Safety and Efficacy of Tag-7 Gene-modified Vaccine in Locally Advanced or Metastatic Malignant Melanoma or Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04180774 Org: User:
Start: 01/31/01 End: 12/31/18 Due: 12/31/19

Stereotactic Radiation Therapy for HE2-positive Oligometastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06299852 Org: User:
Start: 07/01/22 End: 09/01/25 Due: 09/01/26

Short-term Outcomes of Full Bowel Preparation (MBP+OA) for Rectal Resections for Cancer Versus MBP Alone

Phase: N/A Priority: Normal
NCT ID: NCT04592289 Org: User:
Start: 10/30/20 End: 08/31/24 Due: 08/31/25

Clinical Validation of Cervical Cancer Screening Methods

Phase: N/A Priority: Normal
NCT ID: NCT04783649 Org: User:
Start: 07/13/20 End: 07/01/23 Due: 07/01/24